Dianthus Therapeutics | MGTA - Capitalisation Boursière

Prix De L'Action
89.78
Variation Quotidienne
-1.88 -2.05%
Mensuellement
4.59%
Annuel
409.82%
Q2 Prévisions
83.41




Capitalisation Boursière Changement Date
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
Avita Medical AUD 105.47M 35.32M 2025-12
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Organon & Co USD 1.86B 916.43M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pharma Mar EUR 1.35B 283.5M 2025-12
Qiagen NV USD 9.9B 207.4M 2025-12
Revvity USD 10.97B 1.21B 2025-12
Sartorius EUR 16.41B 2.95B 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Viatris USD 14.34B 2.8B 2025-12
Xeris Pharmaceuticals USD 1.3B 12M 2025-12
Zealand Pharma A/S 33.35B 0 2026-04
Zz Pientze Pharmaceu CNY 118.73B 1.94B 2025-09